SCHEMBL7554271

SCHEMBL7554271

COc1cccc2c(-c3cncc(-c4ccc(Cl)cc4)c3)cn(CCN3CCCCC3)c12

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.49
CNR2 P34972 3/20 0.44
FLT1 P17948 3/20 0.44
FLT4 P35916 3/20 0.44
CCR4 P51679 2/20 0.40
FLT3 P36888 1/20 0.40
MCHR1 Q99705 4/20 0.38
KCNH2 Q12809 3/20 0.37
SCN9A Q15858 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
CHRNB1 P11230 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNB3 Q05901 1/20 0.37
SIGMAR1 Q99720 1/20 0.36
GSK3B P49841 1/20 0.36
QPCT Q16769 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7554716 0.95 KDR (0.51) KDRCNR2FLT1FLT4CCR4
SCHEMBL7550092 0.92 KDR (0.49) KDRCNR2FLT1FLT4FLT3
SCHEMBL7990572 0.92 KDR (0.50) KDRCNR2FLT1FLT4GSK3B
SCHEMBL7549676 0.92 KDR (0.50) KDRCNR2FLT1FLT4FLT3
SCHEMBL7551199 0.92 KDR (0.54) KDRCNR2FLT1FLT4FLT3
SCHEMBL7552370 0.87 KDR (0.53) KDRCNR2FLT1FLT4GSK3B
SCHEMBL7547157 0.87 CNR2 (0.40) KDRCNR2FLT1FLT4CHRNB1
SCHEMBL7988115 0.87 KDR (0.49) KDRCNR2FLT1FLT4FLT3
SCHEMBL7553648 0.86 KDR (0.50) KDRCNR2FLT1FLT4HRH3
SCHEMBL7549404 0.86 KDR (0.51) KDRCNR2FLT1FLT4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed